Drug – bio-affecting and body treating compositions – Identification or warning feature – Taste or smell or chemical irritation to the eye – nose – or...
Patent
1988-03-01
1989-12-05
Robinson, Douglas W.
Drug, bio-affecting and body treating compositions
Identification or warning feature
Taste or smell or chemical irritation to the eye, nose, or...
514647, 514649, 514652, 514731, A61K 31135, A61K 3105
Patent
active
048851540
ABSTRACT:
A method and means for reducing sensitization or irritation caused by transdermally delivered drugs, wherein one or more metabolic modulators is coadministered with a sensitizing or irritating drug.
REFERENCES:
patent: 3598122 (1971-08-01), Zaffaroni
patent: 3598123 (1971-08-01), Zaffaroni
patent: 4006218 (1977-02-01), Sipos
patent: 4087538 (1978-05-01), Portnoff
patent: 4144317 (1979-03-01), Higuichi et al.
patent: 4286592 (1981-09-01), Chandrasekan
patent: 4314557 (1982-02-01), Chandrasekan
patent: 4379454 (1983-04-01), Campbell et al.
patent: 4440778 (1984-04-01), Matsui et al.
patent: 4559222 (1985-12-01), Enscore et al.
patent: 4573995 (1986-03-01), Cheng et al.
patent: 4573996 (1986-03-01), Kwiatek et al.
patent: 4645774 (1987-02-01), Toth et al.
Lui et al., "Quantitative Mechanistic Studies on Inhibition of Transdermal Metabolism of B-estradiol by Ethanol," Journal of Pharmaceutical Sciences, vol. 76, No. 11, Nov. 1987 (abstract).
Drill's Pharmacology in Medicine, ed. Joesph R. DiPalma, Third Edition, pp. 41-42, (1965).
Medicinal Chemistry, ed. Alfred Burger, Third Edition, pp. 56-57, (1970).
I. S. Severina, "Effect of Alcohols on Mitochondrial Monoamine Oxidase Activity," Bull. Exp. Biol. & Med., 79 (1), pp. 30-32 (1975).
A. Pannatier et al., "The Skin as a Drug-Metabolizing Organ," Drug Metabolism Reviews, 8(2), pp. 319-343 (1978).
E. A. Zeller et al., "How Do MAO-A and MAO-B Select their Substrates? Thermodynamic Aspects," function and Regulation of Monoamine Enzymes; Basic and Clinical Aspects, E. Usdin et al., editors, pp. 469-476 (1981).
C. J. Fowler et al., "Selective Inhibitors of Monoamine Oxidase A and B: Biochemical, Pharmacological, and Clinical Properties," Medicinal Research Reviews, vol. 4, No. 3, pp. 323-358. (1984).
P. K. Noonan, "Cutaneous Metabolism of Xenobiotics," Percutaneous Absorption, R. L. Bronaugh et al., editors, pp. 65-85 (1985).
Goodman and Gilman's, "the Pharmacological Basis of Therapeutics," Seventh Edition pp. 13-21 (1985).
Goodman and Gilman's, "The Pharmacological Basis of Therapeutics,".
R. J. Martin et al., "Skin Metabolism of Topically Applied Compounds," International Journal of Pharmaceutics, vol. 39, pp. 23-32 (1987).
D. L. J. Opdyke, "Inhibition of Sensitization Reactions induced by Certain Aldehydes," FD. Cosmet. Toxicol. vol. 14, pp. 197-198 (1976).
J. D. Guin et al., "The Effect of Quenching Agents on Contact Urticaria Caused by Cinnamic Aldehyde," J. Amer. Aca. Derm., vol. 10, No. 1, pp. 45-51 (1984).
Amkraut Alfred
Cormier Michel J. N.
Ledger Philip W.
Marty Jean P.
ALZA Corporation
Henley III Raymond J.
Mandell Edward L.
Miller D. Byron
Robinson Douglas W.
LandOfFree
Method for reducing sensitization or irritation in transdermal d does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for reducing sensitization or irritation in transdermal d, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for reducing sensitization or irritation in transdermal d will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2033420